Basil S. Lewis
21 Ehud Street
Haifa, HA, Israel
Haifa, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 152 publications
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
Journal: The New England journal of medicine
Published: August 31, 2026
A farewell to professor Stefan Agewall from the ESC Working Group on Cardiovascular Pharmacotherapy.
A farewell to professor Stefan Agewall from the ESC Working Group on Cardiovascular Pharmacotherapy.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 27, 2026
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy.
Journal: European journal of heart failure
Published: September 28, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.
Journal: Diabetes care
Published: April 22, 2025
Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue.
Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 26, 2024
Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.
Journal: JACC. Advances
Published: December 16, 2024
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC.
Journal: European journal of heart failure
Published: September 26, 2024
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention.
Journal: European heart journal
Published: September 12, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.
Journal: European heart journal
Published: July 22, 2024
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.
Journal: European journal of heart failure
Published: July 03, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.
Journal: American heart journal
Published: June 18, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Last Updated: 09/26/2026